E. Fougera & Co. v. City of New York

120 N.E. 642, 224 N.Y. 269, 1 A.L.R. 1467, 1918 N.Y. LEXIS 879
CourtNew York Court of Appeals
DecidedOctober 15, 1918
StatusPublished
Cited by33 cases

This text of 120 N.E. 642 (E. Fougera & Co. v. City of New York) is published on Counsel Stack Legal Research, covering New York Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
E. Fougera & Co. v. City of New York, 120 N.E. 642, 224 N.Y. 269, 1 A.L.R. 1467, 1918 N.Y. LEXIS 879 (N.Y. 1918).

Opinion

Cardozo, J.

In a controversy submitted on an agreed statement of facts, judgment has been rendered permanently enjoining the enforcement of sections 116 and 117 of the Sanitary Code adopted by the board of health of the city of New York.

Those sections provide in substance that there shall be no sale of patent or proprietary medicines in the city of New York unless “ the names of the ingredients of every such medicine to which the therapeutic effects claimed are attributed, and the names of all other ingredients except such as are physiologically inactive, shall be registered in the department of health.” There is an exception where medicines are prescribed by a physician. The names of the ingredients when registered are to be regarded as confidential and shall not be open to inspection by the public or by any persons other than the official custodian of such records in the department of health, such persons as may be authorized by law to inspect such records, and those duly authorized to prosecute or enforce the federal statutes, the laws of the state of New York, both criminal and civil, and the ordinances of the city of New York, but only for the purpose of such prosecution or enforcement.” With the names there must be filed a copy of all advertising matter sold or distributed in connection with the medicine. Any proprietary or patent medicine shall be deemed to be misbranded if the names of its ingredients are omitted or mistated. Medicines are also to be deemed misbranded if the package or label contains any statement, design, or device, regarding the drug or its ingredients, or regarding its or their action on diseased conditions, *277 which statement, design, or device shall be false or misleading in any particular.” Misbranding may also result from other acts and omissions, not now important. In addition to misbranding, the ordinance prohibits and defines adulteration. One who violates the ordinance may be punished as for a misdemeanor, and is also liable to a penalty of $50 to be recovered in a civil action (Charter, New York City, sec. 1222).

The plaintiff is engaged in the importation and sale, both wholesale and retail, of proprietary and patent medicines. The names of many of the medicines are stated in the record. For some, the plaintiff is the exclusive importer and sole distributor in the United States. A large stock of drugs was on its shelves when the ordinance was passed. It does not know the names of the ingredients and cannot ascertain them. They are secrets closely guarded by the foreign manufacturers. In these circumstances, it insists that the ordinance is void. There have been two lines of attack. The ordinance is said in the first place to infringe rights secured to the plaintiff by the state and the federal Constitution. If not subject to that criticism, it is said to go beyond the scope of the powers which the legislature has delegated to the city’s local officers.

Most of the objections to the ordinance, we reject as inadequate. For the moment, we put aside the consideration of its effect upon existing stores of merchandise. We deal with it at the outset in its relation to merchandise to be acquired in the future.

The argument is made that the ordinance is an abitrary exercise of the power of government. We do not think so. Its purpose and effect are well within the limits of the police power. The purpose is the preservation of the public health and safety (Savage v. Jones, 225 U. S. 501; State v. Aslesin, 50 Minn. 5, 8; State Bd. of Pharmacy v. Matthews, 197 N. Y. 353). The *278 form of protection is publicity. There must be disclosure of the truth to responsible officials who will prevent or punish the sale of fraudulent or noxious compounds. If that is not a legitimate public aim, we are at a loss to know where one may be found. It is not important that the ordinance fails to compel disclosure to all the world. Laws are not invalid because they fall short of the maximum of attainable efficiency. Disclosure to all the world, as in Savage v. Jones (supra), might make the protection more complete, but it would also make the hardship more severe. Something less, therefore, has been exacted. Disclosure is to be made to the health officers of the city, and to them only. If fraud or other wrong is discovered, then and then only exposure will result. “No man has a constitutional right to keep secret the composition of substances which he sells to the public as articles of food ” (State v. Aslesin, supra). If that is true of food, it is even more plainly true of drugs. A danger exists, and the only question is whether the means of correction are appropriate. We cannot say that the means have no relation to the end. The public health is safeguarded by disclosure to public officers charged by law with its protection. We are not called upon to approve the wisdom of the ordinance. We stop when we satisfy ourselves that it has a reasonable relation to the end to be attained.

It is said that the effect of the ordinance is to compel the dealers in patent medicines to give evidence against themselves in violation of section 6 of article I of the Constitution of the state. The basis of that argument is a stipulation in the record “ that the admitted object of defendants in the enactment of said revised Sanitary Code and regulations is to secure information on which to base prosecutions for violations of law, if in their opinion the facts disclosed in accordance therewith shall so warrant.” We are not bound by stipulations in *279 respect of the purpose of legislation. Laws are not to be declared invalid upon the consent of parties. We must determine their purpose and tendency for ourselves. But if the stipulation were to be accepted as accurate, the result would not be changed. The sale of medicines is a business subject to governmental regulation. One who engages in it is not compelled by this ordinance to expose himself to punishment for any offense already committed. He is simply notified of the conditions upon which he may do business in the future. He makes his own choice. To such a situation, the privilege against self-accusation has no just application (People v. Rosenheimer, 209 N. Y. 115; Ex parte Kneedler, 243 Mo. 632, 641; People v. Henwood, 123 Mich. 317; Wigmore Ev. § 2264).

It is said again that prosecution may follow if any statement in respect of the curative action of the drug is false, and that to permit this is to inflict punishment for mere error of opinion (Am. School of Magnetic Healing v. McAnnulty, 187 U. S. 94). We have no doubt, however, that the word “ false as used in the ordinance means willfully false or fraudulent. If this construction is adopted, the objection vanishes (Seven Cases v. U. S., 239 U. S. 510). Willful fault is generally, though not invariably, the determining mark of crime (Wharton Crim. L. [11th ed.] § 151;

Free access — add to your briefcase to read the full text and ask questions with AI

Related

O'CALLAGHAN v. Coghill
888 P.2d 1302 (Alaska Supreme Court, 1995)
In re Daniel C.
99 A.D.2d 35 (Appellate Division of the Supreme Court of New York, 1984)
Joch v. County of Tompkins
95 A.D.2d 84 (Appellate Division of the Supreme Court of New York, 1983)
People v. Kolinsky
111 Misc. 2d 633 (Criminal Court of the City of New York, 1981)
Dresser Industries, Inc. v. Alaska Department of Labor
633 P.2d 998 (Alaska Supreme Court, 1981)
Nishman v. De Marco
76 A.D.2d 360 (Appellate Division of the Supreme Court of New York, 1980)
Tyus v. State
347 So. 2d 1377 (Court of Criminal Appeals of Alabama, 1977)
Kim v. Town of Orangetown
66 Misc. 2d 364 (New York Supreme Court, 1971)
City of Rye v. Metropolitan Transportation Authority
249 N.E.2d 429 (New York Court of Appeals, 1969)
Rockland County Builders Ass'n v. McAlevey
55 Misc. 2d 695 (New York Supreme Court, 1968)
Streb v. City of Rochester
32 Misc. 2d 29 (New York Supreme Court, 1961)
People v. Dawson
207 Misc. 994 (City of New York Municipal Court, 1955)
United States v. Kahriger
345 U.S. 22 (Supreme Court, 1953)
United States v. Forrester
105 F. Supp. 136 (N.D. Georgia, 1952)
People v. Shifrin
198 Misc. 348 (New York County Courts, 1950)
People v. Elkin
196 Misc. 188 (Mount Vernon City Court, 1948)
West v. Bank of Commerce & Trusts
167 F.2d 664 (Fourth Circuit, 1948)
Spiselman v. Rabinowitz
270 A.D. 548 (Appellate Division of the Supreme Court of New York, 1946)
Steinberg v. Stebbins
184 Misc. 794 (New York Supreme Court, 1945)

Cite This Page — Counsel Stack

Bluebook (online)
120 N.E. 642, 224 N.Y. 269, 1 A.L.R. 1467, 1918 N.Y. LEXIS 879, Counsel Stack Legal Research, https://law.counselstack.com/opinion/e-fougera-co-v-city-of-new-york-ny-1918.